BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia

Dysregulation of B cell receptor (BCR) signalling is a hallmark of chronic lymphocytic leukaemia (CLL) pathology, and targeting BCR pathway kinases has brought great therapeutic advances. Activation of the BCR in lymphoid organs has been associated with CLL cell proliferation and survival, leading t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Hematol
Autores principales: Haerzschel, Andrea, Catusse, Julie, Hutterer, Evelyn, Paunovic, Manuela, Zirlik, Katja, Eibel, Hermann, Krenn, Peter W., Hartmann, Tanja N., Burger, Meike
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093209/
https://ncbi.nlm.nih.gov/pubmed/27542958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-016-2788-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares